Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 253
Filter
2.
Eur Rev Med Pharmacol Sci ; 24(19): 10051-10053, 2020 10.
Article in English | MEDLINE | ID: mdl-33090410

ABSTRACT

OBJECTIVE: Long-term survival of patients with neonatal-onset carbamoyl-phosphate synthetase 1 deficiency (CPS1D), an autosomal recessive disorder characterized by repeated, life-threatening hyperammonemia, is rare. We describe the diagnosis and clinical management of a teenager with neonatal-onset CPS1D who did not undergo therapeutic liver transplantation. CASE REPORT: Following emergent neonatal therapy, the patient was diagnosed with CPS1D based on clinical, radiological, biochemical and genetic analyses. Her clinical course, neurobehavioral development and therapeutic interventions are presented and discussed. RESULTS: Born from nonconsanguineous parents, the proband underwent phototherapy for neonatal jaundice, associated with acute encephalopathy, apnea and cerebral edema. Based on blood and urinary biochemical abnormalities, neonatal-onset CPS1D was diagnosed. Her hyperammonemia was corrected by hemodialysis, followed by sodium benzoate, L-arginine, levocarnitine and protein-free diet therapy. Because of a relapse and persistent neurobehavioral regression by age 1, a planned liver transplantation was cancelled. At age 10, sodium phenylbutyrate was substituted as ammonia scavenger. Genetic testing revealed compound heterozygote c.2359C>T (R787X) and c.236+6T>C variants of CPS1, confirming her diagnosis. Despite severe neurological sequelae, the patient is 16 and in stable condition. CONCLUSIONS: Our case suggests that early hemodialysis and pharmacologic interventions for acute neonatal hyperammonemia can improve the prognosis of patients with neonatal-onset CPS1D.


Subject(s)
Arginine/therapeutic use , Brain Diseases, Metabolic/therapy , Carbamoyl-Phosphate Synthase I Deficiency Disease/therapy , Carnitine/therapeutic use , Hyperammonemia/therapy , Phenylbutyrates/therapeutic use , Renal Dialysis , Sodium Benzoate/therapeutic use , Female , Humans , Infant, Newborn
3.
Int J Oral Maxillofac Surg ; 42(8): 962-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23602482

ABSTRACT

The purpose of this study was to evaluate the stability and viability of mandibular bone regeneration using a poly(L-lactide) (PLLA) mesh and autogenous particulate cancellous bone and marrow (PCBM). Sixty-two procedures were undertaken at eight hospitals (22 malignant tumours, 30 benign tumours, five cysts, two osteomyelitis, two trauma, and one atrophy of the alveolar ridge); the success rate was 84%. The follow-up period was between 9 and 200 months (mean 88.2 months). Consequently, bone regeneration at 6 months postoperation was excellent in 35 cases (57%), good in 17 cases (27%), and poor in 10 cases (16%). In six of the 'poor' cases, the PLLA mesh was removed due to local infection early after surgery. Bone resorption>20% was observed in only one of 46 cases with a follow-up term of >1 year. There were no signs of any other adverse effects except in one case where a section of the tray broke off late in the follow-up period. It is concluded that this method is stable and effective due to favourable morphological and functional recovery and low invasiveness. It may thus be a useful alternative procedure for mandibular reconstruction.


Subject(s)
Absorbable Implants , Autografts/transplantation , Bone Marrow Transplantation/methods , Bone Transplantation/methods , Mandibular Reconstruction/methods , Polyesters/chemistry , Surgical Mesh , Adolescent , Adult , Aged , Alveolar Ridge Augmentation/methods , Bone Regeneration/physiology , Bone Resorption/etiology , Child , Female , Follow-Up Studies , Humans , Male , Mandibular Diseases/surgery , Mandibular Injuries/surgery , Mandibular Neoplasms/surgery , Mandibular Reconstruction/instrumentation , Middle Aged , Odontogenic Cysts/surgery , Osteomyelitis/surgery , Postoperative Complications , Prospective Studies , Tissue Scaffolds , Treatment Outcome , Young Adult
5.
J Clin Pharm Ther ; 37(1): 74-7, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21395634

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Calcium channel blockers (CCBs), which have been widely used for the treatment of hypertension and angina pectoris, decrease lower oesophageal sphincter pressure and, as a result, can exacerbate gastrointestinal disease. In a previous study, increased risk of exacerbation of gastrointestinal disease among elderly patients following treatment with CCBs was identified. The prevalence of gastrointestinal diseases has increased in elderly patients, and it is possible that treatment with CCBs may have undesirably influenced this increase. The change in risk of gastrointestinal disease can be estimated by analysing changes in the prescription of antisecretory drugs as an outcome of exacerbation of gastrointestinal disease caused by CCBs. METHODS: It was hypothesized that patients who were prescribed CCBs would also change their use of antisecretory drugs. From September 2005 to August 2009, a dynamic retrospective cohort study was performed at five community pharmacies in Nagasaki, Japan, to assess alteration of antisecretory drug therapy following treatment with CCBs. Correlations with alterations of antisecretory drug therapy were determined by the Cox proportional hazards model. RESULTS AND DISCUSSION: The proposed study included 260 patients who were prescribed CCBs and 155 controls. During the study period, 53 patients were prescribed CCBs and 13 controls altered their antisecretory drug therapy; the hazard ratio was 2·22 (95% CI 1·25-4·26). WHAT IS NEW AND CONCLUSION: Calcium channel blocker treatment of patients with gastrointestinal disease was associated with alteration in frequency of prescription and an increase in dosage of antisecretory drugs. For clinical management of hypertension, alternative antihypertensive drugs may be considered for patients with gastrointestinal diseases. Further studies are required to determine the influence of CCB therapy on gastroesophageal diseases, suggested by the increase in use of antisecretory drugs.


Subject(s)
Calcium Channel Blockers/adverse effects , Gastrointestinal Agents/therapeutic use , Gastrointestinal Diseases/drug therapy , Hypertension/drug therapy , Aged , Aged, 80 and over , Calcium Channel Blockers/therapeutic use , Cohort Studies , Community Pharmacy Services/statistics & numerical data , Dose-Response Relationship, Drug , Female , Gastrointestinal Agents/administration & dosage , Gastrointestinal Diseases/physiopathology , Humans , Japan , Male , Middle Aged , Proportional Hazards Models , Retrospective Studies
6.
Acta Radiol ; 50(7): 806-11, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19629770

ABSTRACT

BACKGROUND: The location of a parotid tumor affects the choice of surgery, and there is a risk of damaging the facial nerve during surgery. Thus, differentiation between superficial and deep lobe parotid tumors is important for appropriate surgical planning. PURPOSE: To evaluate the usefulness of using the parotid duct, in addition to the retromandibular vein, for differentiating between superficial and deep lobe parotid tumors on MR images. MATERIAL AND METHODS: Magnetic resonance images of 42 parotid tumors in 40 patients were reviewed to determine whether the tumor was located in the superficial or deep lobe. In each case, the retromandibular vein and the parotid duct were used to locate the tumor. The parotid duct was only used in cases where the tumor and the duct were visualized on the same image. RESULTS: Using the retromandibular vein criterion, 71% of deep lobe and 86% of superficial lobe tumors were correctly diagnosed, providing an accuracy of 81%. However, the accuracy achieved when using the parotid duct criterion was 100%, although it could be applied to only 28 of the 42 cases. Based on these results, we defined the following diagnostic method: the parotid duct criterion is first applied, and for cases in which it cannot be applied, the retromandibular vein criterion is used. The accuracy of this method was 88%, which was better than that achieved using the retromandibular vein criterion alone. CONCLUSION: The parotid duct criterion is useful for determining the location of parotid tumors. Combining the parotid duct criterion with the retromandibular vein criterion might improve the diagnostic accuracy of parotid tumor location compared to using the latter criterion alone.


Subject(s)
Magnetic Resonance Imaging/methods , Parotid Gland/pathology , Parotid Neoplasms/pathology , Adult , Aged , Contrast Media , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Parotid Gland/surgery , Parotid Neoplasms/surgery , Retrospective Studies
7.
J Clin Pharm Ther ; 33(6): 619-24, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19138239

ABSTRACT

BACKGROUND AND OBJECTIVE: Calcium channel blockers (CCBs) have been widely used for the treatment of hypertension and angina pectoris. It is presumed that CCBs decrease the lower esophageal sphincter pressure and as a result, the risk of gastrointestinal disease may be increased. Since the prevalence of gastrointestinal diseases has increased in elderly patients, it is possible that treatment with CCBs may have contributed to this increase. Therefore, we considered that the risk of exacerbating gastrointestinal disease among elderly patients by CCBs can be estimated by using the prescription ratio of antisecretory drugs as an outcome. METHOD: We hypothesized that patients who are prescribed CCBs would increase the use of antisecretory drugs involving H(2)-receptor antagonists and proton pump inhibitors (PPIs). From January 2001 to December 2005, a dynamic retrospective cohort study was performed at three community pharmacies in Nagasaki city, Japan, to assess the use of antisecretory drugs following treatment with CCBs among elderly patients. The correlation of initiation of antisecretory drugs treatment to maintenance therapy with PPIs was determined by the Cox proportional hazards model. RESULTS: The proposed study includes 303 patients prescribed CCBs and 258 controls. During the study period, 138 patients prescribed CCBs and 66 controls were initiated by giving antisecretory drugs; the hazard ratio was 1.40 (95% confidence interval 1.21-1.63). Eighty two patients taking CCBs and 32 controls were initiated by the maintenance therapy with PPIs; the hazard ratio was 1.48 (95% confidence interval 1.21-1.83). CONCLUSION: Patients who simultaneously initiated the use of antisecretory drugs with CCBs could not be found. Therefore, antisecretory drugs have not been used to prevent the gastrointestinal diseases caused by CCBs. The results obtained in this study suggest that the risk of gastrointestinal disease could be increased by long-term treatment with CCBs for elderly patients.


Subject(s)
Calcium Channel Blockers/adverse effects , Gastrointestinal Diseases/etiology , Histamine H2 Antagonists/therapeutic use , Proton Pump Inhibitors/therapeutic use , Aged , Aged, 80 and over , Calcium Channel Blockers/therapeutic use , Cohort Studies , Esophageal Sphincter, Lower/drug effects , Esophageal Sphincter, Lower/metabolism , Female , Gastrointestinal Diseases/epidemiology , Gastrointestinal Diseases/prevention & control , Humans , Japan/epidemiology , Male , Middle Aged , Prevalence , Proportional Hazards Models , Retrospective Studies
8.
Eur Surg Res ; 39(3): 153-9, 2007.
Article in English | MEDLINE | ID: mdl-17337893

ABSTRACT

The involvement of bacterial translocation in small intestinal ischemia-reperfusion injuries and the efficacy of using anti-CINC antibodies for treatment were investigated. A model for ischemia-reperfusion injury of the small intestine was constructed by clamping the supramesenteric artery (for 90 min) in rats. Anti-CINC antibodies and saline were given just before the induction of ischemia in the treatment group and the control group, respectively. Six hours after reperfusion, bacteria were detected in the mesenteric lymph nodes, but the 'bacteria-positive' rate was significantly lower in the treatment group than in the control group. Bacterial cultures and endotoxins in the blood were negative in both groups up to 24 h later. The plasma cytokine levels showed similar variations, although the increases were significantly lower after reperfusion in the treatment group. In addition, the degrees of neutrophil infiltration and mucosal injury were attenuated in the small intestine, and the structure of the liver was maintained. Furthermore, the 1-week survival was improved. These results suggest that bacterial translocation occurred predominantly via the lymphatic system and that anti-CINC antibody treatment exerted a protective effect against small intestinal ischemia-reperfusion injury.


Subject(s)
Bacterial Translocation/physiology , Chemokines, CXC/immunology , Intestine, Small/physiopathology , Neutrophil Activation/physiology , Reperfusion Injury/physiopathology , Animals , Antibodies/therapeutic use , Chemokine CXCL1 , Cytokines/blood , Endotoxins/blood , Enterococcus faecalis , Escherichia coli , Intestine, Small/microbiology , Intestine, Small/pathology , Male , Morganella morganii , Peroxidase/metabolism , Rats , Rats, Wistar , Reperfusion Injury/drug therapy , Reperfusion Injury/microbiology
9.
Prostate Cancer Prostatic Dis ; 9(2): 173-8, 2006.
Article in English | MEDLINE | ID: mdl-16607388

ABSTRACT

Steroid receptor RNA activator (SRA) was first isolated as a steroid receptor co-activator that functioned as an RNA transcript. Later, we demonstrated that SRA needs to be translated in order to co-activate androgen receptor (AR). Here, we showed that three isoforms of human SRA enhanced AR activities. Small interfering RNA against SRA suppressed AR activities in PC-3 cells transfected with pSG5AR and in LNCaP cells that have an endogenous mutated-AR. Western blot showed that SRA protein was expressed at a higher level in PC-3 than in LNCaP cells, suggesting that SRA may be related to hormone-independent growth of prostate cancer.


Subject(s)
Gene Expression Regulation, Neoplastic , Prostatic Neoplasms/genetics , RNA, Untranslated/genetics , Receptors, Androgen/physiology , Base Sequence , Biomarkers, Tumor/analysis , Blotting, Western , Disease Progression , Humans , Male , Molecular Sequence Data , Prostatic Neoplasms/pathology , RNA, Long Noncoding , RNA, Neoplasm/analysis , RNA, Untranslated/metabolism , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Sampling Studies , Sensitivity and Specificity , Tumor Cells, Cultured/cytology
10.
Int J Oral Maxillofac Surg ; 34(7): 739-44, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15921890

ABSTRACT

The treatment method for early stage tongue cancer is still controversial in Japan. The aim of this study is to compare the prognosis for patients with early tongue cancer treated with brachytherapy and surgery. A retrospective study was conducted to compare the efficacy of low-dose-rate brachytherapy (LDR), high-dose-rate brachytherapy (HDR), and surgery for early tongue cancer. A total of 180 patients with stage I-II tongue cancer were divided into three treatment groups: LDR (78), HDR (26), and surgery (71). Local recurrence was seen in thirteen patients (17%) of the LDR, nine (35%) of the HDR, and four (6%) of the surgery group. After salvage therapy, final local cure was obtained for 71 patients (91%) of the LDR, 22 (85%) of the HDR, and 71 (100%) of the surgery group. Neck failure was recorded for eight patients in the LDR, six in the HDR, and three in the surgery group. The respective 5-year overall survival rates for the LDR, HDR and surgery groups were 84.0%, 72.9%, 95.4% for stage I, and 72.2%, 51.5%, 93.8% for stage II. These findings show that surgery is the optimal treatment method for patients with stage I-II tongue cancer.


Subject(s)
Brachytherapy/methods , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/surgery , Tongue Neoplasms/radiotherapy , Tongue Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Female , Humans , Laser Therapy , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Prognosis , Radiotherapy Dosage , Retrospective Studies , Survival Analysis , Tongue Neoplasms/pathology
11.
Photomed Laser Surg ; 23(1): 47-51, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15782032

ABSTRACT

OBJECTIVE: The aim of the present study was to evaluate and compare the morphological and functional recovery following partial glossectomy in rabbits with the CO(2) laser and electrocautery. METHODS: Partial glossectomy with the CO(2) laser or electrocautery in rabbits was performed to investigate changes in the body weight and tongue width after surgery. The study models were classified into three groups. In group 1, the excised edges of the wound were left unsutured after partial glossectomy with the CO(2) laser. In group 2, the wound was closed after CO(2) laser surgery. In group 3, as a control group, the wound was closed after partial glossectomy with electrocautery. The specimens of the tongues obtained from the rabbit were microscopically assessed. RESULTS: No significant differences were found in the percent change in the body weight among the three groups. There was a significant difference in the tongue width between groups 1 and 3 at each time point: 2 weeks (p < 0.05), 4 weeks (p < 0.01), and 8 weeks (p < 0.001) postoperatively. Furthermore, there was a significant difference in the tongue width between groups 2 and 3 at 8 weeks (p < 0.02) postoperatively. Histologically, the scar tissue of the wound was extensive in the control group, although it was localized in the laser group. CONCLUSION: Postoperative dysfunction was reduced when excised edges were left unsutured after partial glossectomy with the CO(2) laser.


Subject(s)
Electrocoagulation , Glossectomy/methods , Laser Therapy , Tongue/pathology , Wound Healing , Animals , Body Weight , Carbon Dioxide , Male , Rabbits , Tongue/surgery
12.
Mol Psychiatry ; 9(7): 711-7, 2004 Jul.
Article in English | MEDLINE | ID: mdl-14699430

ABSTRACT

Attention-deficit hyperactivity disorder (ADHD) is one of the most common childhood behavioral disorders. Genetic factors contribute to the underlying liability to develop ADHD. Reports implicate variants of genes important for the synthesis, uptake, transport and receptor binding of dopamine in the etiology of ADHD, including DRD4, DAT1, DRD2, and DRD5. In the present study, we genotyped a large multiplex sample of ADHD affected children and their parents for polymorphisms in genes previously reported to be associated with ADHD. Associations were tested by the transmission disequilibrium test (TDT). The sample is sufficient to detect genotype relative risks (GRRs) for putative risk alleles. The DRD4 gene 120-bp insertion/deletion promoter polymorphism displayed a significant bias in transmission of the insertion (chi(2)=7.58, P=0.006) as suggested by an analysis of a subset of these families. The seven repeat allele of the DRD4 48-bp repeat polymorphism (DRD4.7) was not significantly associated with ADHD in the large sample in contrast to our earlier findings in a smaller subset. We replicate an association of a dinucleotide repeat polymorphism near the DRD5 gene with ADHD by showing biased nontransmission of the 146-bp allele (P=0.02) and a trend toward excess transmission of the 148-bp allele (P=0.053). No evidence for an association was found for polymorphisms in DRD2 or DAT1 in this sample. The DRD5 146-bp (DRD5.146) allele and the DRD4 240-bp (DRD4.240) allele of the promoter polymorphism emerge as the two DNA variants showing a significant association in this large sample of predominantly multiplex families with ADHD, with estimated GRRs of 1.7 and 1.37, respectively.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Linkage Disequilibrium , Polymorphism, Genetic , Receptors, Dopamine D1/genetics , Receptors, Dopamine D2/genetics , Adolescent , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Dopamine Plasma Membrane Transport Proteins , Female , Genetic Predisposition to Disease/epidemiology , Haplotypes , Humans , Male , Membrane Glycoproteins/genetics , Membrane Transport Proteins/genetics , Nerve Tissue Proteins/genetics , Receptors, Dopamine D4 , Receptors, Dopamine D5 , Risk Factors
13.
Oral Oncol ; 39(8): 759-69, 2003 Dec.
Article in English | MEDLINE | ID: mdl-13679199

ABSTRACT

Various treatment procedures for oral leukoplakia have been reported. However, after some treatments, oral leukoplakia show recurrence and/or malignant transformation, even following complete resection. Furthermore, patients with oral leukoplakia may develop new lesions in other oral cavity locations. Laser surgery for oral mucosal lesions has been reported to have many advantages, and it is widely used in the treatment of oral leukoplakia. In previous studies, recurrence and malignant transformation from the lesion have occasionally been observed following laser surgery. We reviewed the records of oral leukoplakia patients treated with laser surgery to assess its clinical usefulness. It has been reported that the rate of recurrence was 7.7-38.1%, while malignant transformation was 2.6-9% for oral leukoplakia treated with laser surgery. In the present study, there was 29.3% recurrence and 1.2% malignant transformation after laser surgery. This was similar to previous findings. This suggests that non-homogeneous leukoplakia on nonkeratinized epithelia, i.e. the tongue mucosa has a high risk for malignant transformation, so lesions should be excised after detecting abnormal epithelia using vital tissue staining. The wound healing process after laser surgery was satisfactory and no significant complications were observed. Management of oral leukoplakia prevents not only recurrence and malignant transformation, but also postoperative dysfunction: laser surgery is an excellent procedure that is able to overcome these problems.


Subject(s)
Laser Therapy , Leukoplakia, Oral/surgery , Mouth Mucosa/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Leukoplakia, Oral/pathology , Male , Middle Aged , Mouth Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Postoperative Period
14.
Clin Chim Acta ; 312(1-2): 69-79, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11580911

ABSTRACT

BACKGROUND: It has been recently suggested that cardiac troponin T (cTnT) may be more sensitive than troponin I (cTnI) for subclinical myocardial cell injury in patients on chronic dialysis. METHODS: We prospectively compared the predictive value of cTnT with cTnI, atrial (ANP) and brain natriuretic peptide (BNP) in 100 consecutive outpatients on chronic dialysis without acute coronary syndromes over a period of 3 months, and assessed whether the combination of cTnT with clinical information including age, duration of dialysis, and medical histories was useful for risk stratification of these patients. During the 2-year follow-up period, 19 patients died, mostly due to cardiac causes (53%). RESULTS: The area under the receiver operator characteristic (ROC) curve for the cTnT as predictor of both overall and cardiac death was significantly greater than the area under the cTnI curve (p < 0.0001 and p = 0.01), the BNP curve (p < 0.001 and p < 0.01) or the ANP curve (p < 0.0001 and p < 0.005). In a stepwise multivariate Cox regression analysis, only cTnT (p < 0.05 and p < 0.01) and a history of heart failure requiring hospitalization (p < 0.05 and p < 0.005) were independent predictors of both all cause and cardiac mortality. Using parameters of cTnT > or =0.1 microg/l and/or history of heart failure, the overall and cardiac mortality rate for the low risk group (n=66) were 4.5% and 1.5%, respectively, 40% and 16% for the intermediate risk group (n=25), and 67% and 56% for the high risk group (n=9). CONCLUSION: cTnT concentrations offer a higher prognostic accuracy than cTnI, ANP and BNP in patients on chronic dialysis. The combination of elevated cTnT and a history of heart failure may be a highly effective means of risk stratification of these patients.


Subject(s)
Cardiovascular Diseases/blood , Kidney Failure, Chronic/blood , Troponin T/blood , Adult , Aged , Atrial Natriuretic Factor/blood , Cardiovascular Diseases/mortality , Female , Heart Failure/blood , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/mortality , Male , Middle Aged , Myocardium/metabolism , Natriuretic Peptide, Brain/blood , Predictive Value of Tests , Prospective Studies , ROC Curve , Renal Dialysis , Risk Factors , Survival Rate , Troponin I/blood
15.
Diabetes Care ; 24(10): 1776-82, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11574441

ABSTRACT

OBJECTIVE: The purpose of this study was to evaluate the efficacy of fidarestat, a novel aldose reductase (AR) inhibitor, in a double-blind placebo controlled study in patients with type 1 and type 2 diabetes and associated peripheral neuropathy. RESEARCH DESIGN AND METHODS: A total of 279 patients with diabetic neuropathy were treated with placebo or fidarestat at a daily dose of 1 mg for 52 weeks. The efficacy evaluation was based on change in electrophysiological measurements of median and tibial motor nerve conduction velocity, F-wave minimum latency, F-wave conduction velocity (FCV), and median sensory nerve conduction velocity (forearm and distal), as well as an assessment of subjective symptoms. RESULTS: Over the course of the study, five of the eight electrophysiological measures assessed showed significant improvement from baseline in the fidarestat-treated group, whereas no measure showed significant deterioration. In contrast, in the placebo group, no electrophysiological measure was improved, and one measure significantly deteriorated (i.e., median nerve FCV). At the study conclusion, the fidarestat-treated group was significantly improved compared with the placebo group in two electrophysiological measures (i.e., median nerve FCV and minimal latency). Subjective symptoms (including numbness, spontaneous pain, sensation of rigidity, paresthesia in the sole upon walking, heaviness in the foot, and hypesthesia) benefited from fidarestat treatment, and all were significantly improved in the treated versus placebo group at the study conclusion. At the dose used, fidarestat was well tolerated, with an adverse event profile that did not significantly differ from that seen in the placebo group. CONCLUSIONS: The effects of fidarestat-treatment on nerve conduction and the subjective symptoms of diabetic neuropathy provide evidence that this treatment alters the progression of diabetic neuropathy.


Subject(s)
Aldehyde Reductase/antagonists & inhibitors , Diabetic Neuropathies/drug therapy , Enzyme Inhibitors/therapeutic use , Imidazoles/therapeutic use , Imidazolidines , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/physiopathology , Double-Blind Method , Electrophysiology , Female , Glycated Hemoglobin/analysis , Humans , Hypesthesia , Imidazoles/adverse effects , Male , Middle Aged , Pain , Paresthesia , Placebos
16.
Biol Bull ; 201(1): 26-33, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11526060

ABSTRACT

Mechanisms of gravitactic behaviors of aquatic microorganisms were investigated in terms of their mechanical basis of gravity-dependent orientation. Two mechanical mechanisms have been considered as possible sources of the orientation torque generated on the inert body. One results from the differential density within an organism (the gravity-buoyancy model) and the other from the geometrical asymmetry of an organism (the drag-gravity model). We first introduced a simple theory that distinguishes between these models by measuring sedimentation of immobilized organisms in a medium of higher density than that of the organisms. Ni2+-immobilized cells of Paramecium caudatum oriented downwards while floating upwards in the Percoll-containing hyper-density medium but oriented upwards while sinking in the hypo-density control medium. This means that the orientation of Paramecium is mechanically biased by the torque generated mainly due to the anterior location of the reaction center of hydrodynamic stress relative to those of buoyancy and gravity; thus the torque results from the geometrical fore-aft asymmetry and is described by the drag-gravity model. The same mechanical property was demonstrated in gastrula larvae of the sea urchin by observing the orientation during sedimentation of the KCN-immobilized larvae in media of different density: like the paramecia, the gastrulae oriented upwards in hypo-density medium and downwards in hyper-density medium. Immobilized pluteus larvae, however, oriented upwards regardless of the density of the medium. This indicates that the orientation of the pluteus is biased by the torque generated mainly due to the posterior location of the reaction center of gravity relative to those of buoyancy and hydrodynamic stress; thus the torque results from the fore-aft asymmetry of the density distribution and is described by the gravity-buoyancy model. These observations indicate that, during development, sea urchin larvae change the mechanical mechanism for the gravitactic orientation. Evidence presented in the present paper demonstrates a definite relationship between the morphology and the gravitactic behavior of microorganisms.


Subject(s)
Gravitation , Larva/physiology , Locomotion , Models, Biological , Paramecium/physiology , Sea Urchins , Animals , Biomechanical Phenomena , Larva/drug effects , Mathematics , Nickel/pharmacology , Paramecium/drug effects , Potassium Cyanide/pharmacology , Sea Urchins/growth & development
18.
Exp Lung Res ; 27(2): 157-71, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11258803

ABSTRACT

An association between Epstein-Barr virus (EBV) infection and fibroblast proliferation in the interstitial spaces of the lung has been suggested in idiopathic interstitial pneumonia. In this study we show that EBV can infect human lung fibroblasts in vitro. A primary-cultured human lung fibroblast cell line, designated CCD-32Lu, expressed EBV nuclear antigen 1 after coculture with lethally irradiated EBV producing cells. The infection further induced CCD-32Lu cells to produce the fibrogenic cytokines basic fibroblast growth factor (bFGF) and interleukin-1beta. These findings indicate that lung fibroblasts may be a target for EBV infection and suggest that EBV may play a role in increased production of these cytokines and induce fibroblast proliferation in idiopathic interstitial pneumonia.


Subject(s)
Epstein-Barr Virus Infections/metabolism , Fibroblast Growth Factor 2/biosynthesis , Fibroblasts/virology , Herpesvirus 4, Human/physiology , Interleukin-1/biosynthesis , Antibodies, Blocking/pharmacology , Antibodies, Viral/immunology , Blotting, Western , Cell Division , Cell Line , Coculture Techniques , Enzyme-Linked Immunosorbent Assay , Epstein-Barr Virus Nuclear Antigens/analysis , Epstein-Barr Virus Nuclear Antigens/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Humans , Lung/cytology , Lung Diseases, Interstitial/etiology , Lung Diseases, Interstitial/metabolism , Lung Diseases, Interstitial/virology , Neutralization Tests , Transforming Growth Factor beta/biosynthesis , Transforming Growth Factor beta1
19.
Clin Chim Acta ; 301(1-2): 19-30, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11020459

ABSTRACT

The purpose of this study was to evaluate whether the plasma brain natriuretic peptide (BNP) concentration is a useful marker of right ventricular (RV) overload and whether it has prognostic value as a predictor of death in patients with chronic respiratory disease (CRD). We measured the plasma BNP and atrial natriuretic peptide (ANP) concentrations in 31 consecutive patients with CRD who underwent right-heart catheterization to evaluate pulmonary hypertension. All patients were followed for >12 months. The plasma BNP concentration closely correlated with the mean pulmonary artery pressure and pulmonary vascular resistance (r=0.62, P<0.0005 and r=0. 85, P<0.0001), and showed a weak linear correlation with cardiac output (r=-0.36, P<0.05). During the follow-up period, 5 (16%) end-stage CRD deaths (4 RV heart failure and 1 respiratory infection) and 2 non-end-stage CRD deaths occurred. In a stepwise multivariate Cox proportional-hazards regression analysis including age, sex, BNP, ANP, hemodynamic variables and the ratio of PaO(2) to fraction of inspired oxygen, only BNP (P<0.05) was an independent predictor of end-stage CRD death. The upward and leftward shift in the receiver operating characteristic curve between patients with end-stage CRD death and those without was greater for BNP than for ANP. Our findings suggest that the plasma BNP concentration may be an inexpensive, simple and useful marker of RV overload and end-stage CRD death in CRD patients. These preliminary results need to be confirmed in a large series of CRD patients.


Subject(s)
Heart Ventricles/physiopathology , Lung Diseases/blood , Natriuretic Peptide, Brain/blood , Aged , Chronic Disease , Female , Humans , Lung Diseases/mortality , Lung Diseases/physiopathology , Male , Middle Aged
20.
J Cell Biol ; 150(6): 1445-60, 2000 Sep 18.
Article in English | MEDLINE | ID: mdl-10995448

ABSTRACT

Cell-cell and cell-matrix interactions play a critical role in tissue morphogenesis and in homeostasis of adult tissues. The integrin family of adhesion receptors regulates cellular interactions with the extracellular matrix, which provides three-dimensional information for tissue organization. It is currently thought that pancreatic islet cells develop from undifferentiated progenitors residing within the ductal epithelium of the fetal pancreas. This process involves cell budding from the duct, migration into the surrounding mesenchyme, differentiation, and clustering into the highly organized islet of Langerhans. Here we report that alpha(v)beta(3) and alpha(v)beta(5), two integrins known to coordinate epithelial cell adhesion and movement, are expressed in pancreatic ductal cells and clusters of undifferentiated cells emerging from the ductal epithelium. We show that expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins are developmentally regulated during pancreatic islet ontogeny, and mediate adhesion and migration of putative endocrine progenitor cells both in vitro and in vivo in a model of pancreatic islet development. Moreover, we demonstrate the expression of fibronectin and collagen IV in the basal membrane of pancreatic ducts and of cell clusters budding from the ductal epithelium. Conversely, expression of vitronectin marks a population of epithelial cells adjacent to, or emerging from, pancreatic ducts. Thus, these data provide the first evidence for the contribution of integrins alpha(v)beta(3) and alpha(v)beta(5) and their ligands to morphogenetic events in the human endocrine pancreas.


Subject(s)
Islets of Langerhans , Receptors, Vitronectin/genetics , Stem Cells/cytology , Adult , Age Factors , Animals , Cell Adhesion/physiology , Cell Movement/physiology , Epithelial Cells/chemistry , Epithelial Cells/cytology , Epithelial Cells/transplantation , Extracellular Matrix Proteins/analysis , Extracellular Matrix Proteins/metabolism , Fetal Tissue Transplantation , Fluorescent Antibody Technique , Gene Expression Regulation, Developmental , Humans , Integrins/analysis , Integrins/genetics , Islets of Langerhans/cytology , Islets of Langerhans/embryology , Islets of Langerhans/physiology , Mice , Mice, SCID , Oligopeptides/analysis , Oligopeptides/metabolism , Pancreas Transplantation , Pancreatic Ducts/cytology , Pancreatic Ducts/embryology , Pancreatic Ducts/physiology , Receptors, Vitronectin/analysis , Stem Cell Transplantation , Stem Cells/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL